179 related articles for article (PubMed ID: 34872106)
1. Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia.
Leahy AB; Li Y; Talano JA; Elgarten CW; Seif AE; Wang Y; Johnson B; Monos DS; Kadauke S; Olson TS; Freedman J; Wray L; Grupp SA; Bunin N
Blood Adv; 2022 Feb; 6(4):1175-1185. PubMed ID: 34872106
[TBL] [Abstract][Full Text] [Related]
2. Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia.
Merli P; Algeri M; Galaverna F; Milano GM; Bertaina V; Biagini S; Girolami E; Palumbo G; Sinibaldi M; Becilli M; Leone G; Boccieri E; Grapulin L; Gaspari S; Airoldi I; Strocchio L; Pagliara D; Locatelli F
Front Immunol; 2020; 11():699. PubMed ID: 32477328
[TBL] [Abstract][Full Text] [Related]
3. CD3
Ramanathan S; Lum SH; Nademi Z; Carruthers K; Watson H; Flood T; Owens S; Williams E; Hambleton S; Gennery AR; Slatter M
Transplant Cell Ther; 2023 Aug; 29(8):513.e1-513.e9. PubMed ID: 37279857
[TBL] [Abstract][Full Text] [Related]
4. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
[TBL] [Abstract][Full Text] [Related]
5. Post-Transplantation Cyclophosphamide-Based Haploidentical versus Matched Unrelated Donor Peripheral Blood Hematopoietic Stem Cell Transplantation Using Myeloablative Targeted Busulfan-Based Conditioning for Pediatric Acute Leukemia.
Hong KT; Park HJ; Kim BK; An HY; Choi JY; Kang HJ
Transplant Cell Ther; 2022 Apr; 28(4):195.e1-195.e7. PubMed ID: 35021131
[TBL] [Abstract][Full Text] [Related]
6. Partially CD3
Seif AE; Li Y; Monos DS; Heidemann SC; Aplenc R; Barrett DM; Casper JT; Freedman JL; Grupp SA; Margolis DA; Olson TS; Teachey DT; Keever-Taylor CA; Wang Y; Talano JM; Bunin NJ
Biol Blood Marrow Transplant; 2020 Mar; 26(3):493-501. PubMed ID: 31765697
[TBL] [Abstract][Full Text] [Related]
7. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.
Arnold DE; MacMath D; Seif AE; Heimall JR; Wang Y; Monos D; Grupp SA; Bunin NJ
Transplant Cell Ther; 2021 Feb; 27(2):169.e1-169.e9. PubMed ID: 33830028
[TBL] [Abstract][Full Text] [Related]
8. Unrelated donor vs HLA-haploidentical α/β T-cell- and B-cell-depleted HSCT in children with acute leukemia.
Bertaina A; Zecca M; Buldini B; Sacchi N; Algeri M; Saglio F; Perotti C; Gallina AM; Bertaina V; Lanino E; Prete A; Barberi W; Tumino M; Favre C; Cesaro S; Del Bufalo F; Ripaldi M; Boghen S; Casazza G; Rabusin M; Balduzzi A; Fagioli F; Pagliara D; Locatelli F
Blood; 2018 Dec; 132(24):2594-2607. PubMed ID: 30348653
[TBL] [Abstract][Full Text] [Related]
9. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
[TBL] [Abstract][Full Text] [Related]
10. Mismatched related vs matched unrelated donors in TCRαβ/CD19-depleted HSCT for primary immunodeficiencies.
Laberko A; Sultanova E; Gutovskaya E; Shipitsina I; Shelikhova L; Kurnikova E; Muzalevskii Y; Kazachenok A; Pershin D; Voronin K; Shcherbina A; Maschan M; Maschan A; Balashov D
Blood; 2019 Nov; 134(20):1755-1763. PubMed ID: 31558465
[TBL] [Abstract][Full Text] [Related]
11. Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion.
Locatelli F; Merli P; Pagliara D; Li Pira G; Falco M; Pende D; Rondelli R; Lucarelli B; Brescia LP; Masetti R; Milano GM; Bertaina V; Algeri M; Pinto RM; Strocchio L; Meazza R; Grapulin L; Handgretinger R; Moretta A; Bertaina A; Moretta L
Blood; 2017 Aug; 130(5):677-685. PubMed ID: 28588018
[TBL] [Abstract][Full Text] [Related]
12. Post-Transplantation Immunosuppression After TCRΑβ/CD19 Graft Depletion Does Not Improve HSCT Outcomes in Primary Immunodeficiency.
Laberko A; Idarmacheva A; Glushkova S; Pershin D; Shelikhova L; Maschan M; Maschan A; Balashov D
Transplant Cell Ther; 2022 Mar; 28(3):172.e1-172.e4. PubMed ID: 34875404
[TBL] [Abstract][Full Text] [Related]
13. [Autologous versus unrelated donor stem cell transplantation for adults with primary acute myeloid leukemia in first remission].
Yao JF; Zhang GX; Yang DL; He Y; Wei JL; Zhai WH; Jiang EL; Zhang RL; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2020 May; 41(5):365-372. PubMed ID: 32536132
[No Abstract] [Full Text] [Related]
14. T-cell receptor αβ
Shah RM; Elfeky R; Nademi Z; Qasim W; Amrolia P; Chiesa R; Rao K; Lucchini G; Silva JMF; Worth A; Barge D; Ryan D; Conn J; Cant AJ; Skinner R; Abd Hamid IJ; Flood T; Abinun M; Hambleton S; Gennery AR; Veys P; Slatter M
J Allergy Clin Immunol; 2018 Apr; 141(4):1417-1426.e1. PubMed ID: 28780238
[TBL] [Abstract][Full Text] [Related]
15. A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ
Balashov D; Laberko A; Shcherbina A; Trakhtman P; Abramov D; Gutovskaya E; Kozlovskaya S; Shelikhova L; Novichkova G; Maschan M; Rumiantsev A; Maschan A
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1432-1440. PubMed ID: 29550630
[TBL] [Abstract][Full Text] [Related]
16. CD3
Oved JH; Wang Y; Barrett DM; Levy EM; Huang Y; Monos DS; Grupp SA; Bunin NJ; Olson TS
Biol Blood Marrow Transplant; 2019 Mar; 25(3):549-555. PubMed ID: 30312755
[TBL] [Abstract][Full Text] [Related]
17. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
18. TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis.
Merli P; Algeri M; Galaverna F; Bertaina V; Lucarelli B; Boccieri E; Becilli M; Quagliarella F; Rosignoli C; Biagini S; Girolami E; Meschini A; Del Principe G; Sborgia R; Catanoso ML; Carta R; Strocchio L; Pinto RM; Buldini B; Falco M; Meazza R; Pende D; Andreani M; Li Pira G; Pagliara D; Locatelli F
Blood; 2024 Jan; 143(3):279-289. PubMed ID: 37738655
[TBL] [Abstract][Full Text] [Related]
19. Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients.
Bethge WA; Eyrich M; Mielke S; Meisel R; Niederwieser D; Schlegel PG; Schulz A; Greil J; Bunjes D; Brecht A; Kuball J; Schumm M; Vucinic V; Wiesneth M; Bonig H; Westinga K; Biedermann S; Holtkamp S; Karitzky S; Malchow M; Siewert C; Handgretinger R; Lang P
Bone Marrow Transplant; 2022 Mar; 57(3):423-430. PubMed ID: 34952929
[TBL] [Abstract][Full Text] [Related]
20. Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation.
Ho VT; Kim HT; Aldridge J; Liney D; Kao G; Armand P; Koreth J; Cutler C; Ritz J; Antin JH; Soiffer RJ; Alyea EP
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1196-204. PubMed ID: 21193054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
